Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma

Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma

BackgroundLung squamous cell carcinoma (LUSC) generally correlates with poor clinical prognoses due to the lack of available prognostic biomarkers. This study is designed to identify a potential biomarker significant for the prognosis and treatment of LUSC, so as to provide a scientific basis for cl...

Full description

Bibliographic Details
Main Authors: Cailian Wang, Xuyu Gu, Xiuxiu Zhang, Min Zhou, Yan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
LUSC
E2F pathway
gene signature
prognosis
risk score
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.756096/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.756096/full

Similar Items